BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18630841)

  • 21. Morphometric analysis of AgNORs in tubular and papillary parts of canine mammary gland tumors.
    Juntes P; Pogacnik M
    Anal Quant Cytol Histol; 2000 Jun; 22(3):185-92. PubMed ID: 10872033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
    Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
    Micron; 2007; 38(6):674-9. PubMed ID: 17011198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment.
    Biesterfeld S; Farokhzad F; Klüppel D; Schneider S; Hufnagl P
    Virchows Arch; 2001 May; 438(5):478-84. PubMed ID: 11407476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy.
    Lim SM; Duggan MA; Ruff M; Rahim S; McGregor SE; Green FH
    J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of computerized morphometry combined with AgNOR staining in distinguishing benign from malignant pleural effusions.
    Antonangelo L; Saldiva PH; Amaro Júnior E; Capelozzi VL
    Anal Quant Cytol Histol; 1994 Aug; 16(4):247-52. PubMed ID: 7945700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of argyrophilic nucleolar organizing region protein determinations in nondiagnostic fine needle aspiration samples (due to insufficient cell groups) of thyroid nodules.
    Eröz R; Unluhizarci K; Cucer N; Ozturk F
    Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):226-31. PubMed ID: 24341126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exfoliative cytological assessment of apparently normal buccal mucosa among quid chewers using argyrophilic nucleolar organizer region counts and Papanicolaou staining.
    Mohan BC; Angadi PV
    Acta Cytol; 2013; 57(2):164-70. PubMed ID: 23406917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
    Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
    Plate KH; Rüschoff J; Mennel HD
    Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
    Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleolar organizer regions (NORs) in adenomyosis.
    Madej P; Plewka A; Madej JA; Plewka D; Rutkowski T
    Pathol Res Pract; 2006; 202(6):433-7. PubMed ID: 16513291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
    Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
    Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. An approach to standardization.
    Munakata S; Hendricks JB
    Anal Quant Cytol Histol; 1993 Oct; 15(5):329-34. PubMed ID: 8259974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
    Kim DJ; Lee MH; Park TI; Bae HI
    J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroendocrine differentiation in ovarian mucinous tumors].
    Jiang C; Tan Y; Li E
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):130-3. PubMed ID: 11244965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
    Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
    Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.